Bavarian Nordic appointed Tarja Stenvall as president and CEO, effective Oct. 15, succeeding Paul Chaplin. Stenvall previously led Sanofi’s diabetes and cardiovascular franchise as an executive with a major European footprint, as the Danish vaccine company navigates leadership change after Chaplin’s announced departure earlier in the year.